Safety Alerts weekly digest
Important notice: This digest is gathered automatically from official NHS and government sources. It is provided for information and convenience only — always refer to the original source and follow your practice’s own clinical governance procedures. View the full alert list.
Alerts and Recalls for Drugs and Medical Devices - All
- Continuous renal replacement therapy (CRRT): Consider delayed administration of concurrent echinocandins, such as caspofungin, to reduce the risk of adsorption onto new polyacrylonitrile (PAN)-based filter membranes DSI/2026/014 Original alert (opens in a new tab)
- Class 2 Medicines Recall: Norgine Pharmaceuticals Limited, Pedmarqsi 80 mg/mL solution for infusion, EL(26)A/42 Original alert (opens in a new tab)
Field Safety Notices
PSNC Dispensing & Supply News
- October 2026 Price Concessions 2nd Update Original alert (opens in a new tab)
- Drug Safety Update: New safety measures for antidepressants Original alert (opens in a new tab)
- October 2026 Price Concessions 1st Update Original alert (opens in a new tab)
- MPs call for pharmacist flexibilities and reimbursement review Original alert (opens in a new tab)
- National Patient Safety Alert: StatStrip® beta-ketone testing strips (Nova Biomedical) Original alert (opens in a new tab)
- MHRA Class 2 Medicines Recall: Pedmarqsi 80 mg/mL solution for infusion (Norgine Pharmaceuticals Limited) Original alert (opens in a new tab)
- Medicine Supply Notification: FemSeven Conti® (estradiol 50micrograms and levonorgestrel 7micrograms/24hours) transdermal patches Original alert (opens in a new tab)
No sources selected.
Get the weekly digest by email is run by the existing Haresign Safety Alerts service: sign up or manage your subscription there
Copy for email
Paste into an email, or use the button to copy it.
Copy for a spreadsheet
Tab-separated: paste into Excel or Google Sheets. Columns: Date, Source, Reference, Details, Link.